期刊文献+

PLGA/甲壳胺无纺布三维生物支架的安全性及组织相容性观察 被引量:4

A study on the safety and biocompatibility of a novel scaffold
下载PDF
导出
摘要 目的:观察新型三维生物支架聚丙交酯-乙交酯共聚物[poly(dl-lactide-co-glycolide),PLGA]/甲壳胺无纺布的生物安全性及组织相容性。方法:将PLGA/甲壳胺无纺布三维生物支架植入兔皮下,分别于术后2、4、8、12周进行血常规、肝功能、肾功能检测,观察切口局部情况及心、肝、肾组织学变化,植入支架局部取材进行组织学检查。结果:术后不同时间血常规、肝功能、肾功能检测与术前比较无明显差异(P>0.05),心、肝、肾组织学检查观察均未见病理性改变。体内植入大体观察及组织形态学检查显示其具有良好组织相容性。结论:PLGA/甲壳胺无纺布新型三维生物支架具有良好的生物安全性及组织相容性。 Objective To observe the safety and biocompatibility of a novel scaffold made by poly (dl-lactideco-glycolide) (PLGA) embedding with chitosan nonwoven cloth. Methods Novel scaffolds were subcutaneously implanted in rabbits. Complete blood count was performed, and liver function and renal function were measured at week 2, 4, 8 and 12 after the procedure. The incision sites and the histologic changes in the heart, liver, and kidney were observed. The samples from the scaffolds were histologically detected. Results There were no significant differences in complete blood count, liver function, or renal function at different time points after implantation as compared with the baseline (P 〉 0.05). No pathological changes were observed in the heart, liver, or kidney. The scaffold implant revealed a better biocompatibility. Conclusion The novel scaffold has ideal safety and biocompatibility.
出处 《实用医学杂志》 CAS 2007年第18期2833-2835,共3页 The Journal of Practical Medicine
关键词 组织工程 支架 甲壳胺无纺布 PLGA 生物安全性 生物相容性 Tissue engineering Stents Chitosan nonwoven cloth poly (dl-lactide-co-glycolide) Safety Biocompatibility
  • 相关文献

参考文献9

二级参考文献64

  • 1黄金中,李雪盛,卢择俭,全大萍.新型高孔隙率海绵状聚乳酸支架在软骨组织工程研究和应用中的意义[J].中国组织工程研究与临床康复,2001,10(14):58-59. 被引量:8
  • 2崔鹏程 陈文弦 罗家胜 等.人鼻中隔软骨构建组织工程化软骨[J].中华耳鼻咽喉科杂志,2002,36(1):22-24.
  • 3Britt JC, Park SS. Autogenous tissue-engineered cartilage (Evaluation as an implant material)[J ]. Arch Otolaryngol Head NeckSurg, 1998, 124(7): 671-677.
  • 4Rottez N, Aigner J, Natumann A, et al. Cartilage reconstruction in head and neck surgery, comparison of resorbable polymer scaffolds for tissue engineering of human septal cartilage[J ]. J Biomed Matez Res, 1998, 42(4) : 347 - 356.
  • 5Aigner J, Tegeler J, Hutzler D, et al. Cartilage tissue engineering with novel nonwoven structured biomaterial based on hyaluronic acid benzyl ester[J]. J Biomed Mater Res, 1998, 42(2) : 172 -181.
  • 6Bujia J, Sittinger M, Minuth WW, et al. Engineering of cartilage tissue using bioresorbable polymer fleeces and perfusion culture[J]. Acta Otolaryngol(Stockh), 1995, 115(4) : 307 - 310.
  • 7Falsafi S, Koch RJ. Growth of tissue-engineering human nasoseptal cartilage in simulated microgravity[J ]. Arch Otolaryngol Head Neck Surg, 2000, 126(8): 759-765.
  • 8Wambach BA, Cheung H, Josephson GO. Cartilage tissue engineering using thyroid chondrocytes on a type I collagen matrix[J]. Laryngoscope, 2000, 110(21): 2008-2011.
  • 9Cao YL, Vacanti JP, Paige KT, et al. Transplantation of chondrocytes utilizing a polymer-cell construct to produce tissue-engineered cartilage in the shape of a human ear[J]. Plast Reconstr Surg, 1997, 100(2): 297-302.
  • 10Rodriguez A, Cao YL, Ibarra C, et al. Characteristics of cartilage engineexed from human pediatric auricular cartilage [ J ].Plast Reconstr Surg , 1999, 103(8): 1111-1119.

共引文献14

同被引文献66

引证文献4

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部